Related references
Note: Only part of the references are listed.Chromosome 1p21 deletion is a novel prognostic marker in patients with multiple myeloma
Hong Chang et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Deletion of the short arm of chromosome 1 (del 1p) is a strong predictor of poor outcome in myeloma patients undergoing an autotransplant
Muzaffar H. Qazilbash et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2007)
A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1
John D. Shaughnessy et al.
BLOOD (2007)
Abnormalities of chromosome 1p/q are highly associated with chromosome 13/13q deletions and are an adverse prognostic factor for the outcome of high-dose chemotherapy in patients with multiple myeloma
Ka Lung Wu et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Prognostic value of chromosome 1q21 gain by fluorescent in situ hybridization and increase CKS1B expression in myeloma
R. Fonseca et al.
LEUKEMIA (2006)
Multiple myeloma patients with CKS1B gene amplification have a shorter progression-free survival post-autologous stem cell transplantation
Hong Chang et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Frequent gain of chromosome band 1q21 in plasma-cell dyscrasias detected by fluorescence in situ hybridization: incidence increases from MGUS to relapsed myeloma and is related to prognosis and disease progression following tandem stem-cell transplantation
Ichiro Hanamura et al.
BLOOD (2006)
Significant increase of CKS1B amplification from monoclonal gammopathy of undetermined significance to multiple myeloma and plasma cell leukaemia as demonstrated by interphase fluorescence in situ hybridisation
Hong Chang et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Integration of global SNP-based mapping and expression arrays reveals key regions, mechanisms, and genes important in the pathogenesis of multiple myeloma
Brian A. Walker et al.
BLOOD (2006)
The p53-targeting human phosphatase hCdc14A interacts with the Cdk1/cyclin B complex and is differentially expressed in human cancers
Michelle T. Paulsen et al.
MOLECULAR CANCER (2006)
Genetic risk identifies multiple myeloma patients who do not benefit from autologous stem cell transplantation
H Chang et al.
BONE MARROW TRANSPLANTATION (2005)
Possible roles for activating RAS mutations in the MGUS to MM transition and in the intramedullary to extramedullary transition in some plasma cell tumors
T Rasmussen et al.
BLOOD (2005)
Both IGH translocations and chromosome 13q deletions are early events in monoclonal gammopathy of undetermined significance and do not evolve during transition to multiple myeloma
H Kaufmann et al.
LEUKEMIA (2004)
Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma
CS Debes-Marun et al.
LEUKEMIA (2003)
Deregulated human Cdc14A phosphatase disrupts centrosome separation and chromosome segregation
N Mailand et al.
NATURE CELL BIOLOGY (2002)
Share Paper
